摘要
目的探讨ABCB1 C3435T基因多态性与中国人群中他汀类药物疗效的关系。方法计算机检索PubMed、Web of Science、Cochran Library、CNKI、Wan Fang Data、VIP。检索时间均从建库至2016年8月10日。采用非随机试验性研究的质量评价表进行质量评价。统计分析通过Rev Man 5.3软件实现。结果共纳入4个研究,630名研究对象。显性遗传模型TC+CC vs.TT、隐性遗传模型CC vs.TT+TC、加性遗传模型CC vs.TT中ABCB1 C3435T基因多态性与中国人群中他汀对HDL-C、LDL-C、TC、TG影响的相关性均无统计学意义。结论基于本研究结果,尚不能认为ABCB1 C3435T基因多态性与中国人群中他汀疗效有关联。期待今后针对中国人群开展更大样本、多中心、治疗随访时间较长、高质量的研究。
OBJECTIVE To evaluate the association between ABCB1 C3435T polymorphism and statins effectiveness among Chi- nese population. METHODS Databases including PubMed, Web of Scien, Cochrance Library, CNKI, WanFang Data and VIP were searched to retrieve the relevant references from the start to August 2016. A quality assessment was performed using the Methodological Index for Non-Randomized Studies （MINORS） criteria. Meta-analysis, sensitivity analysis （ RevMan 5.3 ） were all done. RESULTS A total of 4 studies were included for final Meta-analysis,involving 630 participants. The efficacy was evaluated by the change in TC （ to- tal cholesterol）, TG （ triglyceride）, HDL-C （ high density lipoprotein-cholesterol）, and LDL-C （ low density lipoprotein-cholesterol） after statin treatment. The pooled MDs were assessed for the dominant genetic model （ CT ＋ TT vs. CC）, recessive genetic model （ TT vs. CC ＋ CT） and homozygote comparison （TT vs. CC）. Overall, there was no statistically significant association for the four genetic models of statins effectiveness. CONCLUSION There is no association between ABCB1 C3435T polymorphism and statins effective- ness among Chinese population.
出处
《中国药学杂志》
CAS
CSCD
北大核心
2017年第12期1083-1088,共6页
Chinese Pharmaceutical Journal
基金
国家自然科学基金资助项目(81302843)
